Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Roche (RHHBY.US) plans to include MASH new drug in breakthrough therapy
Hong Kong Treasury Department: As of the first quarter of this year, a total of 190 ESG funds have been approved by the Hong Kong Securities and Futures Commission, with assets under management exceeding one trillion Hong Kong dollars.
Shangda Superalloys' shareholder Avic Heavy Machinery intends to inquire about transferring 4.22% of its shares.
Roche (RHHBY.US) plans to include MASH new drug in breakthrough therapy
Hong Kong Treasury Department: As of the first quarter of this year, a total of 190 ESG funds have been approved by the Hong Kong Securities and Futures Commission, with assets under management exceeding one trillion Hong Kong dollars.
Shangda Superalloys' shareholder Avic Heavy Machinery intends to inquire about transferring 4.22% of its shares.
